Literature DB >> 28646959

Is chickenpox so bad, what do we know about immunity to varicella zoster virus, and what does it tell us about the future?

Anne A Gershon1.   

Abstract

Varicella and zoster continue to cause significant morbidity and even mortality in children and adults. Complications include bacterial superinfection, central nervous system manifestations such as meningitis, encephalitis, and cerebellar ataxia, and pain syndromes especially post herpetic neuralgia. Many developed countries but not all, are now administering live attenuated varicella vaccine routinely, with a decrease in the incidence of disease, providing personal and herd immunity. There is some controversy, however, in some countries concerning whether a decrease in the circulation of wild type virus will result in loss of immunity to VZV in persons who have already had varicella. This manuscript reviews the complications of varicella and zoster in detail, the reasons for development of vaccines against these diseases, complications of vaccinations, and mechanisms by which immunity to this virus develops and is maintained. There are strong indications that the best way to control disease and spread of this virus is by vaccination against both.
© 2017 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chickenpox; Latency; Reactivation; Vaccination; Varicella; Zoster

Mesh:

Substances:

Year:  2017        PMID: 28646959      PMCID: PMC5726865          DOI: 10.1016/S0163-4453(17)30188-3

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  83 in total

1.  Varicella in children with cancer: impact of antiviral therapy and prophylaxis.

Authors:  S Feldman; L Lott
Journal:  Pediatrics       Date:  1987-10       Impact factor: 7.124

2.  Fatal varicella associated with selective natural killer cell deficiency.

Authors:  Amos Etzioni; Celine Eidenschenk; Rina Katz; Rafeal Beck; Jean Laurent Casanova; Shimon Pollack
Journal:  J Pediatr       Date:  2005-03       Impact factor: 4.406

3.  Restricted varicella-zoster virus transcription in human trigeminal ganglia obtained soon after death.

Authors:  Werner J D Ouwendijk; Alexander Choe; Maria A Nagel; Don Gilden; Albert D M E Osterhaus; Randall J Cohrs; Georges M G M Verjans
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

4.  Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence.

Authors:  V Williams; A Gershon; P A Brunell
Journal:  J Infect Dis       Date:  1974-12       Impact factor: 5.226

5.  Effectiveness over time of varicella vaccine.

Authors:  Marietta Vázquez; Philip S LaRussa; Anne A Gershon; Linda M Niccolai; Catherine E Muehlenbein; Sharon P Steinberg; Eugene D Shapiro
Journal:  JAMA       Date:  2004-02-18       Impact factor: 56.272

6.  Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged.

Authors:  R Berger; G Florent; M Just
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

Review 7.  Varicella zoster virus infection.

Authors:  Anne A Gershon; Judith Breuer; Jeffrey I Cohen; Randall J Cohrs; Michael D Gershon; Don Gilden; Charles Grose; Sophie Hambleton; Peter G E Kennedy; Michael N Oxman; Jane F Seward; Koichi Yamanishi
Journal:  Nat Rev Dis Primers       Date:  2015-07-02       Impact factor: 52.329

8.  Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox.

Authors:  M Brisson; N J Gay; W J Edmunds; N J Andrews
Journal:  Vaccine       Date:  2002-06-07       Impact factor: 3.641

9.  A model of lytic, latent, and reactivating varicella-zoster virus infections in isolated enteric neurons.

Authors:  Anne A Gershon; Jason Chen; Michael D Gershon
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

10.  Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase 1/2a randomized, placebo-controlled study.

Authors:  Elchonon M Berkowitz; Graeme Moyle; Hans-Jürgen Stellbrink; Dirk Schürmann; Stephen Kegg; Matthias Stoll; Mohamed El Idrissi; Lidia Oostvogels; Thomas C Heineman
Journal:  J Infect Dis       Date:  2014-11-03       Impact factor: 5.226

View more
  11 in total

1.  Bullous varicella in an immunocompetent infant.

Authors:  Siham Mansouri; Sara Mai; Badr Hassam; Laila Benzekri
Journal:  BMJ Case Rep       Date:  2019-03-31

2.  Insights into the pathogenesis of varicella viruses.

Authors:  Océane Sorel; Ilhem Messaoudi
Journal:  Curr Clin Microbiol Rep       Date:  2019-07-06

Review 3.  SARS-CoV-2 Liability: The Hidden Mystery Behind Its Presentation in Children.

Authors:  Reza Jafarzadeh Esfehani; Mohammad Hassan Aelami; Afsaneh Rezaei Kalat; Saman Soleimanpour; Zahra Pasdar; Majid Khazaei; Alireza Pasdar; Amir Avan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Varicella outbreaks in schools and kindergartens in Shanghai, China from 2011 to 2020.

Authors:  Jing Wang; Zhenhui Xu; Qiang Gao
Journal:  PLoS One       Date:  2022-06-30       Impact factor: 3.752

5.  The comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka.

Authors:  Zuhal Umit; Zumrut Sahbudak Bal; Aysin Zeytinoglu; Tansu Gulbahar Aydogan; Ozlem Bag; Gizem Guner Ozenen; Ferda Ozkinay; Zafer Kurugol
Journal:  Hum Vaccin Immunother       Date:  2021-10-13       Impact factor: 4.526

6.  Effectiveness and failure rate of the varicella vaccine in an outbreak in Jiangsu, China: a 1:2 matched case-control study.

Authors:  Yong Wang; Lei Zhang; Xiang Sun; Yang Cao; Zhiguo Wang; Li Liu; Yan Xu; Minghao Zhou; Yuanbao Liu
Journal:  Hum Vaccin Immunother       Date:  2019-10-07       Impact factor: 3.452

Review 7.  Clinical Features of Varicella-Zoster Virus Infection.

Authors:  Peter G E Kennedy; Anne A Gershon
Journal:  Viruses       Date:  2018-11-02       Impact factor: 5.048

8.  Correlates of COVID-19 Vaccine Hesitancy among a Community Sample of African Americans Living in the Southern United States.

Authors:  Justin Xavier Moore; Keon L Gilbert; Katie L Lively; Christian Laurent; Rishab Chawla; Cynthia Li; Ryan Johnson; Robert Petcu; Mehul Mehra; Antron Spooner; Ravindra Kolhe; Christy J W Ledford
Journal:  Vaccines (Basel)       Date:  2021-08-08

9.  Varicella zoster virus vaccines: an update.

Authors:  Giovanni Gabutti; Niccolò Bolognesi; Federica Sandri; Caterina Florescu; Armando Stefanati
Journal:  Immunotargets Ther       Date:  2019-08-06

Review 10.  Varicella-zoster virus post-exposure management and prophylaxis: A review.

Authors:  Anne M Lachiewicz; Megan L Srinivas
Journal:  Prev Med Rep       Date:  2019-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.